Retention in buprenorphine treatment with Albert Burgess-Hull

Retention in buprenorphine treatment with Albert Burgess-Hull

In this episode, Dr Elle Wadsworth talks to Dr Albert Burgess-Hull, the Scientific Director of SUDx and Head Data Scientist at MATClinics, US. The interview covers a short report examining treatment retention in opioid use disorder comparing subcutaneous injectable versus sublingual buprenorphine.

· What is buprenorphine and what it is used for? [01:00]

· The benefits and drawbacks of sublingual versus subcutaneous injectable buprenorphine [01:38]

· An overview of the study [04:41]

· Statistically matching sublingual buprenorphine patients with subcutaneous injectable buprenorphine patients [06:05]

· The main findings of the study [08:34]

· The contrast of Albert’s findings with findings in previous literature [10:03]

· The implications of the findings for clinicians [12:28]

· The take home messages of the study [14:03]


About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. Elle is also a senior analyst at RAND Europe, working on projects focusing on national and international drug policies.

About Albert Burgess-Hull: Albert is an addiction scientist and machine-learning researcher, and is currently the Scientific Director of SUDx and Head Data Scientist at MATClinics. His research focuses on the development and deployment of digital health frameworks to improve medical decision-making, operational efficiency, and the delivery of substance use disorder treatments. Dr Burgess-Hull received his PhD from the University of Wisconsin-Madison and completed postdoctoral fellowship training at the National Institute on Drug Abuse IRP at the National Institutes of Health.


Declarations of interest: Dr Burgess-Hull is employed by MATClinics Services LLC. MATClinics are clinics serving outpatient treatment for opioid, alcohol and stimulant use.

Original article: A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine https://doi.org/10.1111/add.70105


The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.


Hosted on Acast. See acast.com/privacy for more information.

Avsnitt(105)

The Paper Authoring Tool (PAT) with Robert West

The Paper Authoring Tool (PAT) with Robert West

Rob Calder talks to Professor Robert West about the Paper Authoring Tool (PAT). Professor West talks about how PAT can be used in the design and write-up phases of a randomised controlled trials, about how it saves time for reviewers and journals and about how using the PAT can make your research more rigorous, well reported and discoverable. He also discusses the future of research publishing and how computer reading can save months or years on evidence synthesis and how this relates to the Human Behaviour Change Project. There is also a small section on the interaction between computers, humans and chess.West, R. PAT: an on‐line paper authoring tool for writing up randomized controlled trials. Addiction 2021; 116: 1938-1940paperauthoringtool.com Hosted on Acast. See acast.com/privacy for more information.

14 Sep 202127min

Cannabis, opioids and the gateway hypothesis with Jack Wilson

Cannabis, opioids and the gateway hypothesis with Jack Wilson

Jack Wilson talks to Rob Calder about his recent systematic review and meta-analysis on whether cannabis use increases the likelihood of later life opioid use or opioid use disorders. Jack talks about the limitations of the literature, the influence that the gateway hypothesis has had on policy and on some of the different types of studies that explore this issue. Wilson J, Mills K, Freeman TP, Sunderland M, Visontay R, and Marel C. Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Addiction 2021; doi:10.1111/add.15581 https://onlinelibrary.wiley.com/doi/abs/10.1111/add.15581 Hosted on Acast. See acast.com/privacy for more information.

15 Juli 202116min

Cannabis, schizophrenia and genetics with Emma Johnson

Cannabis, schizophrenia and genetics with Emma Johnson

Dr Emma Johnson talks to Rob Calder about shared genetic liabilities for cannabis use disorder and schizophrenia and the role of tobacco smoking. Dr Johnson talks about the implications of this research on the evidence for a causal relationship between cannabis and schizophrenia and for other genetic associations relating to substance use and psychiatric disorders. The episode also covers to ever-fascinating issue of mendelian randomisation. (Be sure to check out episode 22 too!)Johnson E.C., Hatoum A.S., Deak J.D., Polimanti R, Murray R.M., Edenberg H.J., et al. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction 2021 https://doi.org/10.1111/add.15534 Hosted on Acast. See acast.com/privacy for more information.

14 Juni 202116min

Pay for Performance funding and emergency hospital admissions with Thomas Mason

Pay for Performance funding and emergency hospital admissions with Thomas Mason

Rob Calder talks to Dr Thomas Mason about his research on pay for performance models of addiction treatment and how they were associated with increased emergency hospital admissions. Mason T, Whittaker W, Jones A, Sutton M. Did paying drugs misuse treatment providers for outcomes lead to unintended consequences for hospital admissions? Difference-in-differences analysis of a pay-for-performance scheme in England. Addiction 2021 https://doi.org/10.1111/add.15486 Hosted on Acast. See acast.com/privacy for more information.

1 Juni 202119min

Vaping and smoking cessation with Máirtín McDermott and Leonie Brose

Vaping and smoking cessation with Máirtín McDermott and Leonie Brose

Rob Calder talks to Dr Máirtín McDermott and Dr Leonie Brose about their research into the effectiveness of e-cigarettes for quitting smoking.McDermott M.S, East K.A, Brose L.S, McNeill A, Hitchman S.C, Partos T.R. The effectiveness of using e‐cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom. Addiction 2021. https://doi.org/10.1111/add.15474 Hosted on Acast. See acast.com/privacy for more information.

28 Apr 202117min

Alcohol attributable mortality in the Americas with Maristela Monteiro

Alcohol attributable mortality in the Americas with Maristela Monteiro

Rob Calder talks to Dr Maristela Monteiro about deaths in the Americas between 2013 and 2015 that were 100% attributable to alcohol. Chrystoja B.R, Monteiro M.G, Owe G, Pinheiro Gawryszewski V, Rehm J, Shield K. Mortality in the Americas from 2013 to 2015 resulting from diseases, conditions and injuries which are 100% alcohol attributable. Addiction 2021 https://doi.org/10.1111/add.15475 Hosted on Acast. See acast.com/privacy for more information.

12 Apr 202120min

Social norms and smoking behaviour with Katie East

Social norms and smoking behaviour with Katie East

Rob Calder speaks to Dr Katie East about her research into social norms in relation to smoking behaviourEast K, McNeill A, Thrasher JF, Hitchman SC. Social norms as a predictor of smoking uptake among youth: a systematic review, meta‐analysis and meta‐regression of prospective cohort studies. Addiction 2021 https://doi.org/10.1111/add.15427 Hosted on Acast. See acast.com/privacy for more information.

8 Apr 202111min

Heroin use and general population surveys with Jon Caulkins

Heroin use and general population surveys with Jon Caulkins

Rob Calder speaks to Professor Jon Caulkins about his Addiction Opinion & Debate article discussing the difficulties of measuring heroin use with general population surveysReuter P, Caulkins JP, Midgette G. Heroin Use Cannot Be Measured Adequately with a General Population Survey. Addiction 2021 https://doi.org/10.1111/add.15458 Hosted on Acast. See acast.com/privacy for more information.

30 Mars 202116min

Populärt inom Vetenskap

p3-dystopia
paranormalt-med-caroline-giertz
dumma-manniskor
svd-nyhetsartiklar
allt-du-velat-veta
rss-vetenskapligt-talat
kapitalet-en-podd-om-ekonomi
rss-vetenskapspodden
medicinvetarna
rss-ufobortom-rimligt-tvivel
dumforklarat
sexet
det-morka-psyket
bildningspodden
rss-vetenskapsradion-2
rss-vetenskapsradion
halsorevolutionen
rss-i-hjarnan-pa-louise-epstein
rss-spraket
a-kursen